Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PFIZER INC Director's Dealing 2009

Nov 3, 2009

29831_dirs_2009-11-03_b02e3d77-2561-4861-8582-7315c31fc6b4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2009-10-30

Reporting Person: Redmond Cavan M. (Senior Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2009-10-30 Common Stock A 29360 Acquired 43532 Direct
2009-10-30 Common Stock A 17616 Acquired 61148 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 30709 Indirect

Footnotes

F1: The reported transaction constitutes the grant of restricted stock units, which will vest and be settled in shares of Pfizer common stock on the third anniversary of the date of grant, provided that Mr. Redmond remains in the continuous employ of Pfizer until that anniversary date. This grant was made in connection with Mr. Redmond's election as Pfizer's Senior Vice President; Group President - Diversified Businesses effective October 16, 2009.

F2: The reported transaction constitutes the grant of restricted stock units, which will vest and be settled in shares of Pfizer common stock on the third anniversary of the date of grant, provided that Mr. Redmond remains in the continuous employ of Pfizer until that anniversary date. This grant represents a portion of Mr. Redmond's Executive Long-Term Incentive Program Award for 2010.